In 2017 annual meeting of The American Society of Anestehsiologists, a report specifically focused on the efficacy of Botox (onabotulinumtoxinA) in treating migraine in kids. Currently, there are limited migraine treatments that have been properly tested for under-18 crowd.
This report reviews only the charts of people in the age group 8-17 who’ve received Botox treatment for migraine. Each of these patients received 3-4 Botox injections each.
The results observed were encouraging. As compared to pre-treatment, around ¾ of the patient’s experience complete relief as their attacks disappeared. the duration of attacks in some patients dropped drastically, and all those who go attacks observed that they were less severe. You can read the study’s abstract at: A Longitudinal Evaluation of the Effectiveness of BotoxÂ® in Pediatric Patients Experiencing Migraines.
This report had at least two important caveats. First, there is a much higher “placebo effect” with younger crowd. It helpful to first compare Botox treatments with similar available treatments to see if it’s really a lot better or not. One key here is to check the kind of side effects that could be easily avoided by using Botox to treat migraines instead of other treatment options, such as Topamax.
This was a small study, and involved just nine patients. So this kind of study isn’t that authoritative, but we can surely say it sounds significant. At this stage it would be helpful to carry out a larger study so that we can see results that are close to reality.
Even this small study could ring bells for specialists on using Botox for their chronic migraine patients.